Yizhi Xingnao prescription improves the cognitive function of patients after a transient ischemic attack★

Patients with mild cognitive impairment after a transient ischemic attack were included in this study. They were treated with Yizhi Xingnao prescription, ergoloid mesylates or aspirin for 60 days. Evaluation using the Montreal Cognitive Assessment Scale showed that cognitive function was significant...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Donglin, Chu, Xing, Hu, Lingling, Jiang, Shengyang, Hu, Feng, Sun, Junming, Li, Chengwan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Research and Report: Traditional Chinese Medicine and Neuroregeneration
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350129/
https://www.ncbi.nlm.nih.gov/pubmed/25774185
http://dx.doi.org/10.3969/j.issn.1673-5374.2012.06.005
_version_ 1782360142112620544
author Jiang, Donglin
Chu, Xing
Hu, Lingling
Jiang, Shengyang
Hu, Feng
Sun, Junming
Li, Chengwan
author_facet Jiang, Donglin
Chu, Xing
Hu, Lingling
Jiang, Shengyang
Hu, Feng
Sun, Junming
Li, Chengwan
author_sort Jiang, Donglin
collection PubMed
description Patients with mild cognitive impairment after a transient ischemic attack were included in this study. They were treated with Yizhi Xingnao prescription, ergoloid mesylates or aspirin for 60 days. Evaluation using the Montreal Cognitive Assessment Scale showed that cognitive function was significantly improved in all patients, especially after the combined treatment of Yizhi Xingnao and aspirin. The scores from the Montreal Cognitive Assessment Scale were improved overall and the effective treatment rate was as high as 79%, which was higher than patients treated with a combination of ergoloid mesylates and aspirin, or aspirin alone. Our experimental findings indicate that Yizhi Xingnao prescription can improve mild cognitive impairment after a transient ischemic attack, and that it is more effective than ergoloid mesylates.
format Online
Article
Text
id pubmed-4350129
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-43501292015-03-13 Yizhi Xingnao prescription improves the cognitive function of patients after a transient ischemic attack★ Jiang, Donglin Chu, Xing Hu, Lingling Jiang, Shengyang Hu, Feng Sun, Junming Li, Chengwan Neural Regen Res Research and Report: Traditional Chinese Medicine and Neuroregeneration Patients with mild cognitive impairment after a transient ischemic attack were included in this study. They were treated with Yizhi Xingnao prescription, ergoloid mesylates or aspirin for 60 days. Evaluation using the Montreal Cognitive Assessment Scale showed that cognitive function was significantly improved in all patients, especially after the combined treatment of Yizhi Xingnao and aspirin. The scores from the Montreal Cognitive Assessment Scale were improved overall and the effective treatment rate was as high as 79%, which was higher than patients treated with a combination of ergoloid mesylates and aspirin, or aspirin alone. Our experimental findings indicate that Yizhi Xingnao prescription can improve mild cognitive impairment after a transient ischemic attack, and that it is more effective than ergoloid mesylates. Medknow Publications & Media Pvt Ltd 2012-02-25 /pmc/articles/PMC4350129/ /pubmed/25774185 http://dx.doi.org/10.3969/j.issn.1673-5374.2012.06.005 Text en Copyright: © Neural Regeneration Research http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research and Report: Traditional Chinese Medicine and Neuroregeneration
Jiang, Donglin
Chu, Xing
Hu, Lingling
Jiang, Shengyang
Hu, Feng
Sun, Junming
Li, Chengwan
Yizhi Xingnao prescription improves the cognitive function of patients after a transient ischemic attack★
title Yizhi Xingnao prescription improves the cognitive function of patients after a transient ischemic attack★
title_full Yizhi Xingnao prescription improves the cognitive function of patients after a transient ischemic attack★
title_fullStr Yizhi Xingnao prescription improves the cognitive function of patients after a transient ischemic attack★
title_full_unstemmed Yizhi Xingnao prescription improves the cognitive function of patients after a transient ischemic attack★
title_short Yizhi Xingnao prescription improves the cognitive function of patients after a transient ischemic attack★
title_sort yizhi xingnao prescription improves the cognitive function of patients after a transient ischemic attack★
topic Research and Report: Traditional Chinese Medicine and Neuroregeneration
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4350129/
https://www.ncbi.nlm.nih.gov/pubmed/25774185
http://dx.doi.org/10.3969/j.issn.1673-5374.2012.06.005
work_keys_str_mv AT jiangdonglin yizhixingnaoprescriptionimprovesthecognitivefunctionofpatientsafteratransientischemicattack
AT chuxing yizhixingnaoprescriptionimprovesthecognitivefunctionofpatientsafteratransientischemicattack
AT hulingling yizhixingnaoprescriptionimprovesthecognitivefunctionofpatientsafteratransientischemicattack
AT jiangshengyang yizhixingnaoprescriptionimprovesthecognitivefunctionofpatientsafteratransientischemicattack
AT hufeng yizhixingnaoprescriptionimprovesthecognitivefunctionofpatientsafteratransientischemicattack
AT sunjunming yizhixingnaoprescriptionimprovesthecognitivefunctionofpatientsafteratransientischemicattack
AT lichengwan yizhixingnaoprescriptionimprovesthecognitivefunctionofpatientsafteratransientischemicattack

Ejemplares similares